(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PANAPHIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PANAPHIX

ST13

US500000097592485

Class

5

Filing

97592485

Registration

7195224

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

13

Latest update

10/17/2023

Trademark type

Word

Nice classes

5

Filing date

09/15/2022

Registration date

10/17/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/17/2023

Last transaction

10/17/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Gyeonggi-do, KR

Examiner

DYER, ERIN

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Komipharm International Co., Ltd.

Representatives

KWANG YUP CHAE HAUPTMAN HAM, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Chemotherapy medicines; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposesfor the treatment of pain and inflammation associated with cancerthe treatment of cancerthe treatment of leukemia and lymphomathe treatment of metastatic neoplastic diseasesthe treatment of brain tumorscancer stem cell-targeted and drug resistant cancer therapythe treatment of urogenital cancer and its metastasis

Publications

History of USPTO decisions and trademark events.

13 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/17/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/17/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/01/2023

PUBO

PUBLISHED FOR OPPOSITION

08/01/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/12/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/27/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

06/27/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/27/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

06/27/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/27/2023

DOCK

ASSIGNED TO EXAMINER

06/27/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/29/2022

NWAP

NEW APPLICATION ENTERED

09/19/2022

Continuous trademark protection

Get notified about every new filing that threatens PANAPHIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.